induces the activation of ROS during hemodialysis [4] . In this regard, the development of a new biocompatible 4 .51 Ϯ 0.54 cP, P Ͻ 0.01), %DMR (from 2.29 Ϯ 2.17% to memebrane is necessary for reducing oxidative stress by 1 .90 Ϯ 1.49%, P Ͻ 0.01), and RDW-SD (from 54.4 Ϯ 7.6 fL lowering the circulating ROS. to 49.3 Ϯ 5.9 fL, P Ͻ 0.01). On the contrary, these parameters Recently, vitamin E-bonded hemodialyzers have been all worsened in the SU group. EPO dose needed for the treatment of anemia was significantly (P Ͻ 0.05) reduced from developed, which is known to have many favorable ef-5383 Ϯ 2655 U/week to 4235 Ϯ 3103 U/week in the EE group. fects (i.e., the reduction of interleukin-6 release from During these period, mean blood pressure, Kt/V urea, and serum monocytes [5] or improvement of endothelial dysfunc-␤ 2 -microglobulin were not changed between the two groups.
tion [6] 
during hemodialysis). However, there is little
Conclusion. These findings suggest that vitamin E-bonded hemodialyzer is very useful for improving atherosclerosis from information available regarding to what extent they clinia clinical point of view. As one of the underlying mechanisms, cally improve atherosclerosis, although it has been reas well as antioxidant effects, we want to address an important cently reported that this membrane reduces a percentage role of the improvement of rheology of circulating RBCs, which increase in aortic calcification [7] . A significant increase may also help to reduce the requirement of EPO dose in the in the intima-media thickness (IMT) of the carotid artreatment of anemia of ESRD patients.
tery, a good indicator of atherosclerosis, is reported in dialysis patients, as compared with age-matched healthy anism(s) in which vitamin E-bonded dialyzer may exert its favorable effects on atherosclerosis, we consider that . Under the same conditions Japan) or control membrane, which was identical to the as described above, all patients were followed up for 12 CL-EE except that membrane was not bonded to vitamin months. Blood samples were drawn from the arterial site E (CL-SU; Terumo Co., Ltd., Tokyo). There was no of arteriovenous fistula at the start and at the end of distatistical difference in the age and the mean hemodialyalysis session at a 2-day interval. Serum was transferred sis treatment time between each group (Table 1) . Reinto plastic tubes and stored at Ϫ80ЊC until its measuregarding concurrent medications, eicosapentanoic acid ment. Only in the case of the measurement of RBC viswas given in six of 17 patients in the EE group and seven cosity described below, the assay was performed within of 17 patients in the SU group, although statin was not 24 hours and no stored sample was used. used. Prior to the study, there were three kinds of diaEvaluation of atherosclerotic changes lyzer used, regenerated cellulose membrane, polysulfone, and polymethylmetacrylate. However, there was Both carotid arteries were examined using a 7.5 MHz statistically no difference between two groups. Both linear array transducer with high-resolution B-mode groups were prospectively followed up for 1 year. All echography (Aloka, Tokyo, Japan). This device can meathe patients were informed of the purpose of the study sure the arterial wall thickness by 0.1 mm. The carotid and gave their informed consent. The protocol for this arteries were examined bilaterally in the areas of the common carotid artery (1 cm proximal to the dilatation study was approved by the Institutional Review Board. of the carotid bulb), the carotid bifurcation (1 cm proximal to the flow divider), and the internal carotid artery (1 cm distal to the flow divider) according to the method of Burke et al [11] . The IMT was defined as the distance between the leading edge of the lumen-intima echo of the near wall and the leading edge of the media-adventitia echo. The measurements of IMT were made blindly by two carefully trained sonographers. In a separate series of IMT measurements done in another patients, the interobserver coefficient of variation was 8%. To enhance the reproducibility of measurements, standardized interrogation angles were used according to the recommendations described previously [11] . The maximum thickness of the wall was recorded. The existence of plaque was also recorded. In cases where it was hard to tell the difference between plaques and thickened carotid walls, except by being judged as apparent plaques, the plaque was defined as the IMT of more than 1.5 mm. The prevalence of plaques was recorded, but the size was not.
The predialysis mean blood pressure was determined as mean blood pressure ϭ diastolic ϩ (systolic-diastolic)/3.
Analysis of visicosity of RBCs
To measure the viscosity of RBCs, we used cone plate type viscometer (Visconic ED, Tokyo Keiki, Tokyo, Japan). RBCs obtained after the removal of plasma and buffy coat from heparinized blood were washed three times with 0.9% NaCl solutions, and adjusted in 55% 37ЊC and viscosity was measured as a unit of cP (dyne • sec/cm 2 ) 2 minutes after the incubation. Preliminary stud-EPO dose for the treatment of ESRD anemia ies showed that the incubation time required was All the patients had been given EPO intravenously as 2 minutes. Study of the reproducibility of measurements hematocrit was maintained at 30% to 33% with a level showed variable values within 8% of cP. To find how of ferritin between 100 ng/mL and 300 ng/mL. Every oxidative stress would affect cP, we studied the change 2 weeks total counts of RBCs, hemoglobin, and hematoof viscosity shown after an addition of 1 mmol/L CuSO 4 crit were measured and ferritin level was checked every solution. 3 months. If ferritin level was below than 100 ng/mL, we Analysis of DMR of RBCs administered iron intravenously, measuring the ferritin level every month. Under the conditions mentioned Using a scanning electron microscopy, RBCs fixed above, EPO requirements were adjusted every month. with 2% glutaraldehyde were observed at a magnification of ϫ2000. Representative DMR of RBCs obtained Statistical analysis by hemodialysis patients is shown in Figure 1 . A perAll the data are expressed as mean Ϯ SD. Differences centage of any DMR of RBCs was measured according between the two groups were analyzed by an unpaired to the method of Calzavara et al [12] and compared and paired Student t test. Mann-Whitney U test was also between the two groups. used as necessary. The level of statistical significance was defined as P Ͻ 0.05. All the statistical analysis were Analysis of RBC size distribution curve performed with SAS/Windows (version 6.12). RDW-SD of histogram for RBCs distribution curve, shown as a unit of fL, shows a degree of anisocytosis, RESULTS which means a width of RBC distribution at a height of 20% from the bottom of the curve when the peak value All the 34 patients completed the study. Table 1 shows the patient characteristics. There was no difference in of the distribution is 100%. ages, duration of hemodialysis, and mean blood pressure. Regarding hemodialysis efficacy, Q B , Kt/V urea and serum ␤ 2 -microglobulin levels were not different between the two groups. There was also no difference in body mass index (BMI), total cholesterol, triglyceride, or albumin between the two groups.
As shown in Table 2 , Vitamin E-bonded dialyzer significantly (P Ͻ 0.05) decreased IMT, while that of the control group did not, but rather increased significantly. The prevalence of carotid plaque did not change in both the groups before and after this study.
Normal value of viscosity of RBCs was determined to be 3.73 Ϯ 0.15 cP (N ϭ 7) using RBCs obtained from healthy individuals. Regarding the validity of viscosity measurement for oxidative stress, we confirmed that viscosity increased from 3.73 to 7.45 cP 3 hours after 1 mmol/L CuSO 4 addition as an oxidative stress to RBCs obtained from healthy individuals. RBCs viscosity in all these hemodialysis patients showed increased values, which means that hemodialysis patients are clearly under and to 49.3 Ϯ 5.9 fL after 1 year. However, the SU group hemodialysis patients in the SU group showed numerous did not show any improvement (55.3 Ϯ 7.4 fL before, DMR, which were called largely echinocytes, compared 55.8 Ϯ 6.9 fL after 6 months, and 55.1 Ϯ 6.2 fL after to those in the EE group (Fig. 3 c and d) . EE significantly 1 year). decreased the %DMR from 2.29 Ϯ 2.17% to 2.16 Ϯ As shown in Table 2 , EPO dose used for the correction 1.79% after 6 months, and to 1.90 Ϯ 1.49% (P Ͻ 0.01) after 1 year, while the SU group did not statistically of anemia in ESRD was much reduced in the EE group, from 5383 Ϯ 2655 U/week to 4235 Ϯ 3103 U/week (P Ͻ effect of the membrane on atherosclerosis, there is only a report that vitamin E-bonded dialyzer significantly 0.05). In the SU group, on the contrary, EPO dose sigreduces the percentage increase in aortic calcification nificantly increased from 5162 Ϯ 2514 U/week to 6618 Ϯ index (ACI) evaluated by computed tomography (CT) [7] . 2190 U/week (P Ͻ 0.001). Serum levels of ferritin were Regarding repeatability of IMT measurements, there may not significantly different.
be a number of potential limitations to our study. However, we added important evidence by showing that IMT DISCUSSION was improved in the EE group 1 year later in the prospecWe demonstrated that vitamin E-bonded dialyzer was tive controlled study, although the prevalence of plaque clinically useful for the retardation of atherosclerosis was not changed. Although blood pressure control is shown in carotid IMT and to reduce EPO dose needed known to affect the progression of atherosclerosis, mean for the correction of anemia in ESRD. We also showed blood pressure was not changed between the two groups that these favorable effects may be ascribed to the imnor was it altered between before or after this study. provement of rheology of peripheral circulation.
Thus, this favorable effect appears to be due to the use There are insufficient data available as to whether of vitamin E-bonded dialyzer. Our results also confirmed or not vitamin E-bonded dialyzer is indeed useful for the previous reports [13, 14] that EPO dose was reduced atherosclerosis clinically found in ESRD patients, alin patients using vitamin E-bonded dialyzer. though there are many reports showing that this mem-
The vitamin E-modified dialyzer consists of a block brane clearly reduces an oxidative stress. Clinically, it polymer, which masks the hydroxyl groups on cellulose, has been already reported that EPO dose used for the an oleyl alcohol that inhibits platelet aggregation, and a vitamin E coating with antioxidant properties as recorrection of anemia decreased [13, 14] . Concerning the plasma levels of ox-LDL and malondialdehyde (MDA) [7, 9, 20] . Therefore, we did not measure these plasma levels of ox-LDL or MDA in the present study. Likewise it is well known that this membrane improves neutrophil function [20, 21] and reduces superoxide anion radicals [20] . Despite numerous reports regarding the favorable effects of vitamin E-bonded membrane on oxidative stress assessed by such plasma levels as ox-LDL or ROS, Dhondt et al [22] have recently reported that when comparing this membrane with polysulfone membrane regarding acute biocompatibility parameters, no superiority of this membrane versus the biocompatible standard polysulfone membrane could be shown.
Our interest regarding the underlying mechanisms in which the membrane exerts its favorable effect has been directed toward the rheology of circulating RBCs. There are no data available for the effect of vitamin E-bonded membrane on this field. Since RBCs show increased membrane lipid peroxidation, reduced membrane fluidity, and increased osmotic fragility [23] [24] [25] after hemodi- viscosity of RBCs was greater in hemodialysis patients, as compared with that in healthy subjects. After this study, cP increases in the SU group. Therefore, bioincompatibility during hemodialysis is also very important factor ported by Sasaki, Hosoya, and Saruhashi [15] . The favorable effects of vitamin E-bonded hemodialyzer on athto influence rheologic changes, which may lead to the progression of atherosclerosis. Unfortunately, we do not erosclerosis may be ascribed to the reduction of complement and platelet activation. However, our results know the cP value at the induction of hemodialyis in individual cases. It remains unknown to what extent cP described here might be added to one of the underlying mechanisms. The amount of vitamin E immobilized on had been changing until the beginning of this study after hemodialysis induction. There might be a possibility that the surface-modified cellulose membrane was 147.5 Ϯ 17.5 mg/m 2 . Although vitamin E supplementation decP had increased in patients using bioincompatible membrane until the beginning of this study. At all events, we creases the oxidative susceptibility of LDL in renal failure patients on dialysis therapy [2] , it remains unknown clearly demonstrated that vitamin E-bonded dialyzer had been decreasing the viscosity of RBCs as time goes how much immobilized vitamin E corresponds to an oral dose of vitamin E mentioned above. It is recently by as well as other parameters, including %DMR or RDW-SD, while viscosity had been getting worse in the reported that vitamin E-bonded dialyzer provided more effective antioxidant defense than peroral administracontrol SU group. To see the importance of rheologic changes of RBCs in reduction of IMT, we analyzed the tion of vitamin E in hemodialysis patients [9] . While vitamin C, another antioxidant vitamin, is water-soluble, correlation between the two. However, there was no correlation between any parameters of rheologic changes vitamin E is fat-soluble and bound to protein or lipoprotein. Therefore, no elimination is to be expected during and IMT. This may be due to the fact that the change of IMT is too small. Our preliminary study shows that dialysis. Decreased, normal, or even increased plasma concentrations of vitamin E have been described in papatients with chronic renal failure prior to the induction of hemodialysis have increased viscosity and DMR of tients on regular hemodialysis therapy [16] [17] [18] . It remains unknown whether or not an increased plasma level RBCs. Therefore, these rheologic changes are not necessarily ascribed to the mechanical influences caused by of vitamin E per se exerts its favorable effect on atherosclerosis in the EE group. However, we believe that local hemodialysis. Regarding the mechanisms of how the changes of rheology could be related to atherosclerosis, contact of blood to this membrane play an important role for the prevention of atherosclerosis.
there is little direct data available. We speculate as follows. The increased viscosity of RBCs in the circulation There is widespread acceptance of hypothesis that ox-LDL within the arterial wall is a key early event leads to injuries of endothelium, which then activates platelets or neutrophils. Indirectly, ROS or cytokines in the development of atherosclerosis [19] . It has been clearly known that vitamin E-bonded dialyzer decreased are released, or thrombus would be formed. 
